COLCHICINE MYONEUROPATHY: THE ROLE OF RHABDOMYOLYSIS
First published: 29 September 2006
No abstract is available for this article.
REFERENCES
- 1
Lai IC,
Cheng CY,
Chen HH,
Chen WY,
Chen PY.
Colchicine myoneuropathy in chronic renal failure patients with gout
(Case Report).
Nephrology (Carlton)
2006; 11: 147–50.
- 2
Phanish MK,
Krishnamurthy S,
Bloodworth LL.
Colchicine-induced rhabdomyolysis.
Am. J. Med.
2003; 114: 166–7.
- 3
Chattopadhyay I,
Shetty HG,
Routledge PA,
Jeffery J.
Colchicine induced rhabdomyolysis.
Postgrad. Med. J.
2001; 77: 191–2.
- 4
Boomershine KH.
Colchicine-induced rhabdomyolysis.
Ann. Pharmacother.
2002; 36: 824–6.
- 5
Sinsawaiwong S,
Phanthumchinda K,
Jongpiputvanich S.
Colchicine-induced myopathy in renal failure.
J. Med. Assoc. Thai.
1997; 80: 667–70.
- 6
Ozgur B,
Kursat S.
Hypokalemic rhabdomyolysis aggravated by diuretics complicating Conn’s syndrome without acute renal failure.
Clin. Nephrol.
2002; 57: 89–91.
- 7
Shintani S,
Shiigai T,
Tsukagoshi H.
Marked hypokalemic rhabdomyolysis with myoglobinuria due to diuretic treatment.
Eur. Neurol.
1991; 31: 396–8.
- 8
Brucato A,
Bonati M,
Gaspari F et al.
Tetany and rhabdomyolysis due to surreptitious furosemide – Importance of magnesium supplementation.
J. Toxicol. Clin. Toxicol.
1993; 31: 341–4.
- 9
Morris I,
Varughese G,
Mattingly P.
Colchicine in acute gout.
BMJ
2003; 327: 1275–6.
